| pubmed-article:9822004 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0024109 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0028128 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0002164 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:9822004 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
| pubmed-article:9822004 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9822004 | pubmed:dateCreated | 1998-11-30 | lld:pubmed |
| pubmed-article:9822004 | pubmed:abstractText | The partition of pulmonary blood flow between normal and shunting zones is an important determinant of oxygen tension in arterial blood (PaO2). The authors hypothesized that the combination of inhaled nitric oxide (iNO) and almitrine infusion might have additional effects related to their pharmacologic properties to improve PaO2. Such a combination was tested in patients with hypoxia caused by focal lung lesions, distinct from the acute respiratory distress syndrome. | lld:pubmed |
| pubmed-article:9822004 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9822004 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9822004 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9822004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9822004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9822004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9822004 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9822004 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9822004 | pubmed:issn | 0003-3022 | lld:pubmed |
| pubmed-article:9822004 | pubmed:author | pubmed-author:MaterMM | lld:pubmed |
| pubmed-article:9822004 | pubmed:author | pubmed-author:BeloucifSS | lld:pubmed |
| pubmed-article:9822004 | pubmed:author | pubmed-author:KermarrecNN | lld:pubmed |
| pubmed-article:9822004 | pubmed:author | pubmed-author:GatecelCC | lld:pubmed |
| pubmed-article:9822004 | pubmed:author | pubmed-author:PaveySS | lld:pubmed |
| pubmed-article:9822004 | pubmed:author | pubmed-author:MuretJJ | lld:pubmed |
| pubmed-article:9822004 | pubmed:author | pubmed-author:GuinardNN | lld:pubmed |
| pubmed-article:9822004 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9822004 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:9822004 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9822004 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9822004 | pubmed:pagination | 1157-65 | lld:pubmed |
| pubmed-article:9822004 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:meshHeading | pubmed-meshheading:9822004-... | lld:pubmed |
| pubmed-article:9822004 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9822004 | pubmed:articleTitle | Inhaled nitric oxide, almitrine infusion, or their coadministration as a treatment of severe hypoxemic focal lung lesions. | lld:pubmed |
| pubmed-article:9822004 | pubmed:affiliation | Department of Anesthesiology and Critical Care Medicine, U.F.R. de Médecine Lariboisière-Saint-Louis, Université Paris VII, France. didier.payen@hol.fr | lld:pubmed |
| pubmed-article:9822004 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9822004 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9822004 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
